Audrey Bunch, PA
Surgical · Warrenton, VANPI 1245480318
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $930 of the $1,085 with a category attached, or 85.7%. It is spread thinly across 17 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 43 payments — averaging $25.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$192
- Johnson & Johnson$167
- Novartis$131
- Sun Pharmaceutical Industries Inc.$117
- Pfizer$76
- LEO Pharma Inc.$63
- plus $338 from 11 others
What the payments were for
- Food & beverage$93086%
- Education$15514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $192 |
| Johnson & Johnson | 3 | $167 |
| Novartis | 5 | $131 |
| Sun Pharmaceutical Industries Inc. | 5 | $117 |
| Pfizer | 5 | $76 |
| LEO Pharma Inc. | 2 | $63 |
| Organogenesis Inc. | 1 | $46 |
| Incyte Corporation | 2 | $45 |
| Sanofi | 1 | $40 |
| Lilly USA, LLC | 2 | $38 |
| EPI Health, LLC | 2 | $33 |
| Almirall LLC | 2 | $32 |
| UCB, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Organon | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
How this compares
$1,085 in reported general payments places this provider in the 70th percentile of 201 surgical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $72,794 |
| Clobetasol Propionate | 29 | $1,421 |
| Fluorouracil | 13 | $1,155 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 12 | $712 |
| Metronidazole | 11 | $558 |
| Triamcinolone Acetonide | 25 | $228 |
| Ketoconazole | 31 | $203 |
| Mupirocin | 20 | $163 |
Paid to pharmacies, not to this prescriber.
Other surgical in Warrenton
- Jeanine GargiuloAlexandria$298K
- Kelly LohmannWoodbridge$88K
- Alan FitchRichmond$66K
- Kristin LuptonFairfax$16K
- Tyler KempRoanoke$13K
- Rebecca LehmanCharlottesville$11K
- Savannah WrightRoanoke$10K
- Kathryn RobertsonCharlottesville$8K
- Juliana BuendiaReston$7K
- Taylor FrickeCharlottesville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.